title: [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
authors.affiliation: Instytutu Gruźlicy i Chorób Płuc.
authors.forename: E
authors.initials: E
authors.lastname: Rowińska-Zakrzewska
authors.forename: A
authors.initials: A
authors.lastname: Słupek
authors.forename: J
authors.initials: J
authors.lastname: Graczyk
authors.forename: Z
authors.initials: Z
authors.lastname: Zwolska-Kwiek
authors.forename: E
authors.initials: E
authors.lastname: Augustynowicz-Kopeć
authors.forename: A
authors.initials: A
authors.lastname: Stambrowska
authors.forename: D
authors.initials: D
authors.lastname: Byszewska
authors.forename: E
authors.initials: E
authors.lastname: Latoś
authors.forename: A
authors.initials: A
authors.lastname: Pilarska
authors.forename: Z
authors.initials: Z
authors.lastname: Andrzejczyk
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009170:Nontuberculous Mycobacteria / Q000187:drug effects*; D017828:Rifabutin; D012294:Rifamycins / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D012294:Rifamycins; D017828:Rifabutin
vernacular_title: Wstepne wyniki leczenia ryfabutyna (ansamycyna LM 427) chorych na nowo wykryta i przewlekła gruźlice płuc oraz na mykobakteriozy.